Serum pepsinogen levels and their infiuencing factors: A population-based study in 6990 Chinese from North China

World Journal of Gastroenterology

Volumn 13, Issue 48, 2007, Pages 6562-6567

  Sun, Li Ping ^a   Gong, Yue Hua ^a   Wang, Lan ^a   Yuan, Yuan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Gastric cancer; Helicobacter pylori; Pepsinogen; Screening

Indexed keywords

IMMUNOGLOBULIN G; PEPSINOGEN; PEPSINOGEN I; PEPSINOGEN II;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CANCER SCREENING; CHINA; CHINESE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; STOMACH CANCER; STOMACH MUCOSA;

EID: 38349013424     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.13.6562     Document Type: Article

References (34)

1. Gritti I, Banfi G, Roi GS. Pepsinogens: physiology, pharmacology pathophysiology and exercise. Pharmacol Res 2000; 41: 265-281
2. Kageyama T. Pepsinogens, progastricsins, and prochymosins: structure, function, evolution, and development. Cell Mol Life Sci 2002; 59: 288-306
3. Samloff IM. Pepsinogens I and II purification from gastric mucosa and radioimmunoassay in serum. Gastroenterology 1982; 82: 26-33
4. Samloff IM, Varis K, Ihamaki T, Siurala M, Rotter JI. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology 1982; 83: 204-209
5. Samloff IM, Taggart RT. Pepsinogens, pepsins, and peptic ulcer. Clin Invest Med 1987; 10: 215-221
6. Sipponen P, Harkonen M, Alanko A, Suovaniemi O. Diagnosis of atrophic gastritis from a serum sample. Minerva Gastroenterol Dietol 2003; 49: 11-21
7. Vaananen H, Vauhkonen M, Helske T, Kaariainen I, Rasmussen M, Tunturi-Hihnala H, Koskenpato J, Sotka M, Turunen M, Sandstrom R, Ristikankare M, Jussila. A, Sipponen P. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Heratol 2003; 15: 885-891
8. Miki K, Morita M, Sasajima M, Hoshina R, Kanda E, Urita Y. Usefulness of gastric cancer screening using the serum pepsinogen test method. Am J Gastroenterol 2003; 98: 735-739
9. Mukoubayashi C, Yanaoka K, Ohata H, Arii K, Tamai H, Oka M, Ichinose M. Serum pepsinogen and gastric cancer screening. Intern Med 2007; 46: 261-266
10. Ohata H, Oka M, Yanaoka K, Shimizu Y, Mukoubayashi C, Mugitani K, Iwane M, Nakamura H, Tamai H, Arii K, Nakata H, Yoshimura N, Takeshita T, Miki K, Mohara O, Ichinose M. Gastric cancer screening of a high-risk population in Japan using serum pepsinogen and barium digital radiography. Cancer Sci 2005; 96: 713-720
11. Miki K. Gastric cancer screening using the serum pepsinogen test method. Gastric Cancer 2006; 9: 245-253
12. Dinis-Ribeiro M, Yamaki G, Miki K, Costa-Pereira A, Matsukawa M, Kurihara M. Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening. J Med Screen 2004; 11: 141-147
13. Checchi S, Montanaro A, Pasqui L, Ciuoli C, Cevenini G, Sestini F, Fioravanti C, Pacini F. Serum ghrelin as a marker of atrophic body gastritis in patients with parietal cell antibodies. J Clin Endocrinol Metab 2007; 92: 4346-4351
14. Zhang XH, Zhao WY, Sun XM, Bu YH, Yan X, Wang JL, Wang HY, Zhang ZG, Mi JM, Xie TX, San JSY, Qing MYX, Wang F. Radioimmunological Analysis on Serum Pepsiogen and Gastrin of Rural Adult Residents in High Risk Area of Gastric Cancer. Zhongguo Gonggong Weisheng 2002; 18: 287-288
15. Yuan Y. Comprehensive Prevention and Treatment for High Risk Population in High Risk Area With Gastric Cancer in Zhuanghe Region, Liaoning Province. Zhongguo Zhongliu 2005; 14: 307-311
16. Lin SR, Yu ZL, Hu PJ, Wang CW, Xu GM, Xiao SD, Shi R, Liu WZ. Consensus on chronic gastritis formulated at the national symposium. Zhonghua Xiaohua Zazhi 2000; 20:199-201
17. Dixon MF, Genta RM Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-1181
18. Hokkanen S, Kosunen TU, Sarna S, Miettinen A, Salomaa A, Aromaa A, Knekt P, Rautelin HI Normal serum pepsinogen I levels in adults: a population-based study with special reference to Helicobacter pylori infection and parietal cell antibodies. Scand J Clin Lab Invest 2005; 65: 291-299
19. Veenendaal RA, Biemond L Pena AS, van Duijn W, Kxeuning J, Lamers CB. Influence of age and Helicobacter pylori infection on serum pepsinogens in healthy blood transfusion donors. Gut 1992; 33: 452-455
20. Aoki K, Misumi J, Kimura T, Zhao W, Xie T. Evaluation of cutoff levels for screening of gastric cancer using serum pepsinogens and distributions of levels of serum pepsinogen I, II and of PG I/PG II ratios in a gastric cancer case-control study. J Epidemiol 1997; 7:143-151
21. Korstanje A, den Hartog G, Biemond I, Lamers CB. The serological gastric biopsy: a non-endoscopical diagnostic approach in management of the dyspeptic patient: significance for primary care based on a survey of the literature. Scand J Gastroenterol Suppl 2002; 22-26
22. Di Mario F, Moussa AM, Caruana P, Merli R, Cavallaro LG, Cavestro GM, Dal Bèo N, Iori V, Pilotto A, Leandro G, Franzè A, Rugge M. 'Serological biopsy' in first-degree relatives of patients with gastric cancer affected by Helicobacter pylori infection. Scand J Gastroenterol 2003; 38: 1223-1227
23. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992; 52: 6735-6740
24. Miki K, Sasajima M, Ohtsuka T, Urita Y. Pepsinogen I, pepsinogen II and pepsinogen I/II ratio. Nippon Rinsho 2005; 63 Suppl 8: 741-743
25. Miki K, Urita Y. Using serum pepsinogens wisely in a clinical practice. J Dig Dis 2007; 8: 8-14
26. Kato M, Asaka M, Shimizu Y, Nobuta A, Takeda H, Sugiyama T. Relationship between Helicobacter pylori infection and the prevalence, site and histological type of gastric cancer. Aliment Pharmacol Ther 2004; 20 Suppl 1: 85-89
27. Lee YC, Lin JT, Wu HM, Liu TY, Yen MF, Chiu HM, Wang HP, Wu MS, Hsiu-Hsi Chen T. Cost-effectiveness analysis between primary and secondary preventive strategies for gastric cancer. Cancer Epidemiol Biomarkers Prev 2007; 6: 875-885
28. Mukoubayashi C, Yanaoka K, Ohata H, Arii K, Tamai H, Oka M, Ichinose M. Serum pepsinogen and gastric cancer screening. Intern Med 2007; 46: 261-266
29. Broutet N, Plebani M, Sakarovitch C, Sipponen P, Mégraud F; Eurohepygast Study Group. Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics. British Journal of Cancer 2003; 88: 1239-1247
30. Ernst PB, Peura DA, Crowe SE. The translation of Helicobacter pylori basic research to patient care. Gastroenterology 2006; 130: 188-206; quiz 212-213
31. International Agency for Research on Cancer. Schistosomes, live flukes and Helicobacter pylori. LARC monographs on the evaluation on carcinogenic risks to humans. Vo161. Lyon: LARC, 1994:177-240
32. Lorente S, Doiz O, Trinidad Serrano M, Castillo J, Lanas A. Helicobacter pylori stimulates pepsinogen secretion from isolated human peptic cells. Gut 2002; 50:13-18
33. Ohkusa T, Miwa H, Nomura T, Asaoka D, Kurosawa A, Sakamoto N, Abe S, Hojo M, Terai T, Ogihara T, Sato N. Improvement in serum pepsinogens and gastrin in longterm monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients. Aliment Pharmacol Ther 2004; 20 Suppl 1: 25-32
34. Lin HZ, Yuan Y, Zhang GF, Gao H, Bai XW. Campylobacterpyloridis infection of gastric mucosa in the high and low risk areas of stomach cancer in China. Zhongguo Aizheng Yanjiu 1993; 5: 101-104